[
  {
    "protocol_id": 8473,
    "uploadDate": "new Date('09/04/2016')",
    "protocol": "Sample-ProtSample-ProtSample-ProtSample-ProtSample-ProtSample-Prot",
    "protocol_sponsor": "Eli Lilly",
    "projectId": "123456789",
    "phase": 1,
    "is_active": true,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 0,
   "indication":"ABCC4444",
    "sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "fileName": "Sample-ProtSample-ProtSample-ProtSadfsfdsfdsfdsfdsfsdfdsfdsfdsfdsfdsfdsfsfdsle-Prot",
    "protocol_document_path": "/dummy.pdf",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8474,
    "uploadDate": "new Date('09/06/2016')",
    "protocol": "Test-Prot",
    "protocol_sponsor": "Biogen",
    "projectId": "123456789",
    "phase": 1,
    "is_active": true,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 2,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "fileName": "Sample-Prot-document",
    "protocol_document_path": "/Boilerplate.docx",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8475,
    "uploadDate": "new Date('09/07/2016')",
    "protocol": "Sample-Protocol",
    "protocol_sponsor": "Biogen",
    "projectId": "123456789",
    "phase": 1,
    "is_active": true,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 3,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8476,
    "uploadDate": "new Date('09/08/2016')",
    "protocol": "Example-text-test-0123456789",
    "protocol_sponsor": "Amgen",
    "projectId": "123456789",
    "phase": 1,
    "is_active": true,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 5,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8477,
    "uploadDate": "new Date('09/09/2016')",
    "protocol": "Sample-Prot",
    "protocol_sponsor": "Jansen",
    "projectId": "123456789",
    "phase": 1,
    "is_active": true,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 77,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8478,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 6,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8479,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 7,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8480,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 8,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8481,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 9,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8482,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 10,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8483,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 11,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8484,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "is_active": true,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 12,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8485,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 13,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8481,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 14,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8482,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 15,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8483,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 16,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8484,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "is_active": true,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 17,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8485,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 18,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8473,
    "uploadDate": "new Date('09/04/2016')",
    "protocol": "Sample-Prot",
    "protocol_sponsor": "Eli Lilly",
    "projectId": "123456789",
    "phase": 1,
    "is_active": true,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 19,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "fileName": "Sample-Prot",
    "protocol_document_path": "/dummy.pdf",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8474,
    "uploadDate": "new Date('09/06/2016')",
    "protocol": "Test-Prot",
    "protocol_sponsor": "Biogen",
    "projectId": "123456789",
    "phase": 1,
    "is_active": true,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 20,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "fileName": "Sample-Prot-document",
    "protocol_document_path": "/Boilerplate.docx",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8475,
    "uploadDate": "new Date('09/07/2016')",
    "protocol": "Sample-Protocol",
    "protocol_sponsor": "Biogen",
    "projectId": "123456789",
    "phase": 1,
    "is_active": true,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 21,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8476,
    "uploadDate": "new Date('09/08/2016')",
    "protocol": "Example-text-test-0123456789",
    "protocol_sponsor": "Amgen",
    "projectId": "123456789",
    "phase": 1,
    "is_active": true,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 22,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  },
  {
    "protocol_id": 8482,
    "uploadDate": "new Date('09/10/2016')",
    "protocol": "Demo-Prot",
    "protocol_sponsor": "Hutchinson Medipharma",
    "projectId": "123456789",
    "phase": 1,
    "created_by": "string",
    "created_on": "2020-12-08T08:15:41.091Z",
    "modified_by": "string",
    "modified_on": "2020-12-08T08:15:41.091Z",
    "id": 23,
    "is_active": true,
   "indication":"ABCC4444",
"sponsor": "Giloblastoma",
    "documentStatus": "finalApproved",
    "protocolTitle": "A Multicenter, Randomized, Phase Ib/II Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of MSC2156119J as Monotherapy Versus Sorafenib in Asian Subjects with MET+ Advanced Hepatocellular Carcinoma and Child-pugh class A Liver Funciton"
  }
]
